Saint Mary’s Hospital Leads New England with Cutting-Edge Robotic Treatment for Enlarged Prostates

Transforming Lives with the HYDROS™ Robotic System

Saint Mary’s Hospital has taken a groundbreaking step in the treatment of benign prostatic hyperplasia (BPH), becoming the first hospital in New England to offer Aquablation® therapy using the new HYDROS™ Robotic System. This advanced AI-powered platform is transforming the way enlarged prostates are treated, offering men a minimally invasive solution that preserves continence and sexual function.

A Patient's Journey: Joe's Experience with Aquablation Therapy

For Joe, a 69-year-old Air Force veteran, BPH had become a major obstacle in his active lifestyle. Frequent urination, sleep disruption, and excruciating pain led him to seek medical intervention. "I didn’t know I had an issue with an enlarged prostate, so I let it go. But I waited too long, and I ended up in the emergency room with kidney issues and a bowel obstruction," Joe shared.
After a series of tests and consultations, Joe met Abram D’Amato, M.D., a urology specialist with Trinity Health Of New England, who recommended Aquablation therapy. "First off, I really admire Dr. D’Amato. Great doctor and very personable. He followed up with me from pre-surgery to post-surgery, ensuring all was going fine. He explained that the robotic procedure had fewer side effects than traditional treatments."

The results were life changing. "I had the surgery on a Friday, was discharged on Saturday, and by Sunday, I was out snow blowing. A week later, I noticed a major improvement. I wasn’t frequently going to the bathroom anymore, and I could fully empty my bladder," Joe recalled. "Now, I’m back to walking 10 miles a day, lifting weights, and planning my next deep-sea fishing trip."

A Breakthrough in Prostate Treatment

BPH affects millions of men worldwide, often leading to severe health issues such as bladder or kidney damage, bladder stones, and incontinence. Traditional treatments often come with risks, including complications affecting sexual function. With the introduction of Aquablation therapy, men no longer have to choose between symptom relief and quality of life.

York Paul Moy, M.D., Regional Director, Men’s Health Institute, emphasized the significance of this innovation. "Being the first hospital in New England to offer this service displays our commitment to investing in the latest technology. Not only that, but it also ensures the best outcomes for our patients, keeping them at the center of all we do."

Aquablation therapy uses real-time ultrasound guidance and robotic-assisted waterjet technology to precisely remove excess prostate tissue while protecting critical structures. The HYDROS Robotic System enhances this process with AI-driven FirstAssist AI™ treatment planning, advanced imaging, and robotic precision, ensuring a safer and more effective procedure.

The Future of Prostate Care

With five years of clinical data demonstrating significant, durable symptom relief, Aquablation therapy is quickly becoming the gold standard in BPH treatment. The introduction of the HYDROS Robotic System at Saint Mary’s Hospital marks a significant advancement in men’s health, giving patients like Joe a new lease on life.

"I’ll be golden soon," Joe said with confidence, looking forward to more rounds of golf and fishing trips. "I’m just grateful to have my quality of life back."

As Saint Mary’s Hospital continues to lead the way in robotic-assisted treatments, men across New England now have access to a revolutionary procedure that prioritizes both effectiveness and long-term well-being.

Expanding Urology Services at Trinity Health Of New England

Building on its leadership in innovative urological treatments like Aquablation therapy, Trinity Health Of New England's Urology Department provides a full spectrum of urology services and is quickly growing to offer more providers with expanded capabilities through advanced technologies and treatments. Patient safety and satisfaction are among the key priorities for the Urology team, working to develop and advance new technologies for better patient outcomes. The use of minimally invasive urological surgical techniques is balanced with established protocols and treatments.

The Ureteroscopy (URS) and Lithotripsy program has been extremely successful. These procedures address kidney stones which impact 1 in 500 Americans each year, offering patients surgical options that best fit their condition.

Additionally, the Emergency Department Stone Program at Saint Mary's Hospital helps facilitate continuity of care. Through the efforts of a nurse care manager, patients are followed up with and treated for their emergent kidney stones.

To schedule your appointment with a Men's Health Institute provider or for more information on services visit www.trinityhealthofne.org/men